Product Information

AMLODIPINE-VALSARTAN 5-160 MG is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.2758 per EA under NDC 23155084409. Its NADAC has been published 163 times since Jul 12, 2023.

FDA first approved this application on Mar 28, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN 5-160 MG

amlodipine and valsartan
$0.2758per EA

Strength

5; 160 mg/1; mg/1

NDC

23155084409

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

AMLODIPINE; VALSARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA090011

FDA Approved

3/28/2013

TE Code

AB

On Market Since

3/15/2023

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN 5-160 MG has been published 163 times since Jul 12, 2023, and over the history we have for it it has declined 44.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2758 per EA
All-time high$0.5159 (Apr 10, 2024)
All-time low$0.2758 (Aug 19, 2026)
52-week high$0.4927
52-week low$0.2758
Median price$0.4662
Average price$0.4525
Largest weekly change+35.2% (Aug 21, 2024)
Weeks tracked163
Tracking sinceJul 12, 2023

Price History

1W

-9.3%

1M

-9.3%

3M

-33.5%

6M

-37.8%

1Y

-44.0%

3Y

-43.5%

5Y

N/A

All

-44.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN 5-160 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-160 MG, manufactured by Heritage Pharmaceuticals Inc., is $0.2758 per EA (NDC 23155084409), effective Aug 19, 2026.

How has the price of AMLODIPINE-VALSARTAN 5-160 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has declined 44.5%. It has been tracked across 163 weekly CMS publications since Jul 12, 2023.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-160 MG?

Since Jul 12, 2023, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has ranged from a low of $0.2758 (Aug 19, 2026) to a high of $0.5159 (Apr 10, 2024), with a median of $0.4662 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-160 MG?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-VALSARTAN 5-160 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-VALSARTAN 5-160 MG?

AMLODIPINE-VALSARTAN 5-160 MG (NDC 23155084409) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.